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During the past 10 years, hemodial-
ysis has progressed from a dangerous 
procedure requiring one or more phy-
sicians in constant attendance, to a 
safe nurse-technician activity. Simi-
larly, the indications for initiating di-
alytic therapy have changed as the 
procedure has been simplified and 
made almost completely innocuous. It 
is now felt that one should not wait 
for the patient to develop advanced 
uremia before placing him on the 
artificial kidney, but instead one should 
use this newer method of treatment 
before the complications of uremia set 
in. But dialysis should not be looked 
upon as a substitute for good medical 
management; on the contrary, pre-
dialytic management is more important 
now than ever. The most important 
use for dialysis remains in acute renal 
failure. More recently, however, it has 
been used for the maintainance of 
life in chronic uremia (Pendras and 
Drickson, 1965; Gombos et al., 1964), 
the treatment of many cases of poison-
ing (Maher and Schreiner, 1965) and 
to support renal homotransplantation 
(Bower and Magee, 1964). 
At the Medical College of Virginia 
(MCV) the great majority of dialyses 
have been done in conjunction with 
the transplant program now under way 
(Hume et al., 1964). In addition, there 
has been a significant increase in the 
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number of dialyses done for acute renal 
failure and poisoning. There has been 
no dialysis done for the maintainance 
of life in chronic uremia. The purpose 
of this paper is to give a brief resume 
of the development of the artificial 
kidney unit at MCV, and to report on 
the results of its use. 
It has been less than 15 years since 
MCV acquired its first artificial kidney 
machine. This cumbersome and com-
plicated monster was referred to affec-
tionately as the "rotating drum." It 
required several physicians to operate 
it but it did give all those involved 
with its operation considerable confi-
dence and encouragement that dialysis 
did work. The next machine that was 
purchased was the twin coil kidney. 
This instrument greatly simplified the 
procedure of dialysis and aroused the 
interest of many workers in the field 
both at MCV and throughout the 
world. The greatest burst of enthusi-
asm for dialysis at MCV occurred in 
the fall of 1962 when it was decided 
to undertake studies in renal homo-
transplantation in man. The dialysis 
facilities at that time consisted of the 
twin coil machine and peritoneal lav-
age. This latter method of dialysis 
had recently enjoyed a rejuvenation 
with the appearance on the market of 
commercially available prepackaged 
sterile peritoneal dialysis fluid. 
It soon became apparent that both 
of these methods of dialysis could not 
meet the demands of the transplant 
program. For this reason, in January 
of 1963, the hospital purchased its 
first Kiil kidney (Kiil, 1960). This 
machine was designed originally to 
replace the human kidney during acute 
renal failure. Later it was found to be 
well suited for the maintainance of 
life in chronic uremia and it is today 
used in the majority of successful 
chronic dialysis programs. After few 
modifications it was found that it was 
likewise made suitable for supporting 
a transplant program. The next major 
advance in the dialysis program at 
MCV again grew out of necessity. 
The kidneys were being operated in 
several different areas of the hospital, 
inefficiently. It became apparent that 
larger and more permanent quarters 
. were needed to meet the ever-increas-
ing demands of the transplant program 
as well as the increasing volume of 
acute dialysis. In the fall of 1964, the 
present dialysis unit was completed on 
4 North of the main hospital building 
and I 0 Kiil dialyzers were located in 
this area. This space consisted of ap-
proximately 1100 square feet divided 
so that there would be a supporting 
laboratory and a patient dialysis area. 
As many as 6 dialyses can be done 
simultaneously in this area, with fa-
cilities available for dialysis at all 
times. 
Method of Dialysis 
Each candidate for dialysis has a 
silastic teflon shunt (fig. 1) inserted 
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Fig. 1.-Arterio-venous shunt worn by patients that are on repeated dialysis. 
Fig. 2.-The Kiil Artificial Kidney showing the two blood inlets at the middle of 
the right end and the singly larger bath outlet. The Harvard pump on the second 
shelf is used to infuse heparin to prevent blood clotting inside the artificial kidney. 
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under local anesthesia in a small pe-
ripheral artery and vein. When the 
patient is not on the artificial kidney, 
blood is allowed to flow from the artery 
into the vein to maintain a constant 
flow of blood, thereby preventing clot 
formation. This mechanically exterior-
ized A-V fistula has not been known 
to produce cardiac decompensation 
and it does avoid the need for re-
peated cutdowns. Before this technique 
was devised the number of dialyses that 
could be done in any one patient was 
limited. 
The dialyzer itself (fig. 2) is quite 
simple in design and function. Its sole 
purpose is to create a large surface 
area with a minimum volume of blood 
out of the patient in contact with the 
bath solution on the other side of the 
cellophane membrane. The bath solu-
tion consists of a physiologically bal-
anced electrolyte solution plus glucose 
to adjust the osmolarity. The volume 
of blood necessary to fill the dialyzer 
and thereby give 0.9 M' of dialyzing 
surface is only 350 ml. This small 
volume eliminates the necessity of 
transfusions when using the Kiil dia-
lyzer. When the patient is placed on 
dialysis, the A-V shunt is cross-
clamped and the continuity of the 
shunt disrupted. The arterial line of 
the shunt is connected to the dialyzer 
inlet and the patient is bled into the 
dialyzer, replacing the heparinized sa-
line and filling the dialyzer blood com-
partment. When blood begins to appear 
in the dialyzer outlet line, it is con-
nected to the venous side of the shunt. 
Blood then flows continuously from the 
patient through the dialyzer and back to 
the patient. At the end of the pro-
cedure, the blood in the dialyzer is 
returned to the patient by flushing it 
back in with saline. The net loss of 
blood per dialysis is 30 to 50 ml. Blood 
pumping is not necessary, but it is done 
in some centers to speed up the rate of 
dialysis and reduce the time spent on 
the kidney. Without blood pumping, 
it usually requires two 12 hour periods 
of dialysis per week to maintain an 
anephric patient asymptomatic of 
uremia. The rate of blood flow through 
the dialyzer without pumping is ap-
proximately 100 to 150 ml per minute. 
The bath solution flows at the rate of 
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approximately 500 ml per minute and 
is then discarded. By running the bath 
solution through the dialyzer only once 
and then discarding it, several patients 
can be run from a single bath source, 
providing they can all tolerate the same 
bath composition. This entire pro-
cedure is executed by especially trained 
nurses and technicians, thereby freeing 
the physician completely. The major 
role of the physician in a dialysis 
center is to care for the patients off 
dialysis, and to decide when dialysis 
should be carried out. The physician 
must also occasionally modify the 
bath formula as deemed necessary ac-
cording to the patient's individual 
needs. There is no reason to feel that 
any physician who has taken the 
time to make himself aware of the 
benefits of dialysis and what can be 
expected of the procedure, should not 
be able to order this service when indi-
cated. 
Results and Discussion 
Dialysis with Transplants 
During 1962, 15 dialysis were done. 
Six of these were done in conjunction 
with the transplant program on 3 pa-
tients and the remaining 9 were for 
acute tubular necrosis and barbituate 
intoxication on 6 patients. In 1963, 
there were 195 dialysis done, and in 
1964, 507. The great majority of the 
dialyses in 1963 and 1964 were for 
the transplant program, using primarily 
the Kiil kidney. 
Between August 1962 and April 
1965, 63 renal homotransplants were 
carried out in 57 patients. Four pa-
tients were transplanted twice and one 
patient had 3 transplants. In order to 
support this program, 760 hemodialy-
ses were done. The distribution of these 
dialyses is shown in Table 1. 
Most pertinent to this discussion are 
the data on patients that were never 
transplanted. These 61 dialyses were 
done in 11 patients, all of whom are 
now dead. Five of the first ten admis-
sions to the transplant program died 
before they could be transplanted. We 
attribute this to inadequate dialysis 
facilities. Peritoneal dialysis was used 
in four of these five patients and these 
four had significant peritonitis that 
TABLE 1 
Hemodialysis with Transplantation 
Average 
Number dialyses 
of per 
Dialyses trans-
plant 
---
Pre-transplant 614 11 .6 
Post-transplant 39 2.6 
< 2 weeks 
Post-transplant 30 6.0 
>2 weeks 
Patient never 61 5.5 
transplanted 
Patients awaiting 16 4.0 
transplant 
Total 760 
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contributed to their demise in uremia. 
For this reason, it is felt that peritoneal 
dialysis is not adequate to support a 
transplant program. The remaining 6 
deaths occurred evenly distributed over 
the subsequent 58 admissions. There-
fore, by instituting an active dialysis 
program, the mortality rate prior to 
transplantation was reduced from 50% 
to 10.3%. Looking now at the six 
deaths that occurred after dialysis fa-
cilities were adequate, we find that one 
of these was preventable. This oc-
curred in a six year old male who was 
being dialyzed for the first time. He 
was in congestive heart failure and was 
receiving digitalis. When his serum po-
tassium was lowered by the artificial 
kidney to normal levels he developed 
digitalis intoxication and died of ven-
tricular fibrillation. The remaining five 
deaths pre-transplant were attributable 
to septicemia in two, brain stem hemor-
rhage in one, and gastrointestinal 
hemorrhage in one. One patient re-
fused further dialysis and transplan-
tation. 
Dialysis for Acute Renal Failure, 
Chronic Renal Disease and Poison-
ing 
Since the development of our exist-
ing artificial kidney unit, the volume 
of acute dialysis has likewise increased. 
As stated earlier in 1962 only 6 pa-
tients other than transplant patients 
received dialysis. This number in-
creased to 9 in 1963 and 15 in 1964. 
The 24 patients that were dialyzed 
between Jan. 1, 1963, and Dec. 31, 
1964 are divided into three groups. 
The first group was made up of eleven 
patients who had acute renal failure 
with otherwise normal kidneys (table 
2). The second group, comprising 10 
patients, included those with known 
chronic renal disease, but with super-
imposed reversible features (table 3). 
The third group consisted of three pa-
tients with attempted suicide, who were 
dialyzed to remove the ingested toxin 
(table 4). 
The results of dialysis are most re-
warding in acute renal failure. In our 
own series of eleven patients, seven re-
gained sufficient function to bring 
their BUN and creatinine back to nor-
mal, and in five of these that were 
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TABLE 2 
Dialysis for Acute Renal Failure 
Number 
Patient Etiology of Results t 
Dialyses · 
1 K.S. j Cortical Necrosis, 14 Transplanted, l Post-partum Hemorrhage Died. 
2 J.C. A.T.N.*, Gunshot 3 B 
3 C.H. A.T.N., Septicemia 3 A 
4 Z.T. A.T.N., Septicemia 5 A 
5 R.J. A.T.N., Abruptio 1 A 
6 C.B. A.T.N., CCI, 2 A 
7 G.S. A.T.N., Pancreatitis 1 B 
8 w.c. A.T.N., Ethylene glycol 4 A 
9 J .B . A.T.N., Septicemia 6 Died 
10 J.R. Acute Vasculitis 2 Died 
11 M.B . A.T.N ., Hemorrhage 2 Died 
* A.T.N.- Acute Tubular Necrosis;t Classification of results: A, GFR > 75 cc/ 
min, B, patient alive BUN and creatinine normal, but no evaluation ofG.F.R. avail-
able. 
TABLE 3 
Dialysis for Chronic Renal Disease with Reversible Features 
Pa-
Number 
tient Etiology of Acute failure of Results* Dialyses 
- - -
1 E.D. Iatrogenic Acidosis 1 Lived 6 months 
2 JW. Pyelonephritis 1 Lived 2 weeks 
3 J.P. Accelerated Hypertension 6 Lived 1 week 
4 B.C. Pyelonephritis 4 Transplanted, Died 
5 S.C. Pyelonephritis 3 Lived 2 months 
6 E.L. Pyelonephritis 2 Lived 3 weeks 
7 R.D . Dehydration 2 Lived 3 weeks 
8 A.S. Pyelonephritis 4 Lived 1 month 
9 A.C. Pyelonephritis, A.T.N. 1 Lived 1 day 
10 N .J. Heart failure due to rheumatic disease 2 Lived 1 month 
* Duration of life after last dialysis. 
TABLE 4 
Dialysis for Attempted Suicide and Intoxications 
Number 
Patient Drug or Toxin of Results 
Dialyses 
1 E.S. Combination of Drugs Living and well 
2 W.G . Barbiturates Living and well 
3 J .C . cc1. Died 
checked with creatinine clearance 
studies, all were found to have a clear-
ance of greater than 75 ml per minute. 
There were four deaths in this group. 
Of these, two were probably not dia-
lyzed long enough or frequently 
enough, as borne out by the fact that 
they died in uremia. One patient (J.R.) 
with an acute vasculitis of unknown 
etiology died with azotemia of a sig-
nificant degree, but it is not felt that 
renal failure was the cause of death. 
The fourth death occurred in a pa-
tient with renal cortical necrosis fol-
lowing a complicated delivery. The 
patient was maintained on the artificial 
kidney for eight weeks. At the end of 
this period, an open biopsy of the kid-
ney revealed cortical necrosis. The pa-
tient was then bilaterally nephrecto-
mized and transplanted. 
In our present state of knowledge, 
it appears that the prognosis for a 
patient living through an episode of 
acute tubular necrosis is more depend-
ent on the prognosis of the underlying 
disease than on the tubular necrosis it-
self. In our own experience, we have 
maintained a bilaterally nephrecto-
mized patient on dialysis in a reasona-
ble state of good health for over 14 
months. Scribner et al. now have some 
essentially anephric patients that are 
doing quite well after 5 years on dial-
ysis. 
In those patients with chronic renal 
disease who suddenly become decom-
pensated due to a superimposed acute 
insult, the results are not as good. Here 
again the prognosis is determined by 
the underlying chronic renal disease 
and the availability of chronic dialysis 
facilities. 
Dialysis is very useful in the man-
agement of drug intoxication and at-
tempted suicides. First, it promptly 
removes the offending agent from the 
blood, and secondly, it shortens the 
period of unconsciousness, thereby 
reducing the complications of coma. 
Summary 
Hemodialysis is a safe acceptable 
method of treatment for drug intoxi-
cation, and acute renal failure. It is 
also useful in the management of pa-
tients with chronic renal disease either 
on a periodic basis or, intermittantly, 
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for acute exacerbations superimposed 
on chronic renal insufficiency. The 
great majority of dialysis at MCV 
has been done in conjunction with the 
ongoing renal homotransplantation 
program. Here dialysis has proven to 
be an innocuous procedure and has 
contributed significantly to the suc-
cess of this program. 
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